R.G.C.C. Group was established in 2004 by Dr. Ioannis Papasotiriou.
R.G.C.C. Group is a global organization working in collaboration with branch offices and distributors to provide a world-wide service. Our collaborators are well-established and our work together is prolific.
The company is a pioneering, innovative organisation working in the fields of medical genetics and, in particular, cancer genetics, chemosensitivity and chemo-resistance testing and in Research and Development within the pharmaceutical industry via R.G.C.C. Pharma Ltd
The company headquarters are in Switzerland, and our brand new, state-of-the art laboratories in Northern Greece are equiped with the most up-to-date technologically advanced and innovative equipment.
Our primary concern is for the welfare of cancer patients seeking the very best personalized and integrated treatments and to ensure that clinicians have access to the most up-to-date information which can benefit their patients.